Comparison of clinical efficacy between a single administration of long-acting gonadotrophin-releasing hormone agonist (GnRHa) and daily administrations of short-acting GnRHa in in vitro fertilization-embryo transfer cycles

Journal of Korean Medical Science

Volumn 23, Issue 4, 2008, Pages 662-666

  Kang, Woo Cheon ^b   Sang, Jin Song ^b   Bum, Chae Choi ^b   Seung, Chul Lee ^a   Hong, Bok Lee ^a   Seung, Youn Yu ^a   Keun, Jai Yoo ^b  

^a Samsung Advanced Institute of Technology (SAIT)   (South Korea)

^b Creation and Love Women's Hospital   (South Korea)

Author keywords

Goserelin; In vitro fertilization embryo transfer; Long acting GnRHa; Patient's convenience; Recombinant FSH

Indexed keywords

BUSERELIN; FOLLITROPIN; GOSERELIN; LEUPRORELIN;

ADULT; ARTICLE; COMPARATIVE STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN;

ADULT; BUSERELIN; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GOSERELIN; HUMANS; LEUPROLIDE;

EID: 50449107632     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2008.23.4.662     Document Type: Article

References (24)

1. Loumaye E. The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer. Hum Reprod 1990; 5: 357-76.
2. Smitz J, Van Den Abbeel E, Camus M, Devroey P, Tournaye H, Van Steirteghem AC. The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in vitro fertilization outcome in normo-ovulatory women. Hum Reprod 1992; 7: 1098-102.
3. Tummon IS, Daniel SA, Kaplan BR, Nisker JA, Yuzpe AA. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropin in 408 first cycles of in vitro fertilization. Fertil Steril 1992; 58: 563-8.
4. Dimitry ES, Bates SA, Oskarsson T, Margara R, Winston RM. Programming in vitro fertilization for a 5- or 3-day week. Fertil Steril 1991; 55: 934-8.
5. Polan ML, Daniele A, Russell JB, DeCherney AH. Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function. J Clin Endocrinol Metab 1986; 63: 1284-91.
6. Testart J, Forman R, Belaisch-Allart J, Volante M, Hazout A, Strubb N, Frydman R. Embryo quality and uterine receptivity in in-vitro fertilization cycle with or without agonists of gonadotrophin-releasing hormone. Hum Reprod 1989; 4: 198-201.
7. Tur-Kaspa I, Confino E, Dudkiewicz AB, Myers SA, Friberg J, Gleicher N. Ovarian stimulation protocol for in-vitro fertilization with gonadotropin-releasing hormone agonist widens the implantation window. Fertil Steril 1990; 53: 859-64.
8. Frydman R, Belaisch-Allart J, Parneix I, Forman R, Hazout A, Testart J. Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonist in an in vitro fertilization program. Fertil Steril 1988; 50: 471-5.
9. Abdalla HI, Ahuja KK, Leonard T, Morris NN, Honour JW, Jacobs HS. Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in assisted conception program. Fertil Steril 1990; 53: 473-8.
10. Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de Koppel P, Collins JA. The routine use of gonadotrophin-releasing hormone agonists prior to in-vitro fertilization and gamete intra-fallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992; 58: 888-96.
11. Ron-El R, Herman A, Golan A, van der Ven H, Caspi E, Diedrich K. The comparison of early follicular and midluteal administration of long acting gonadotropin-releasing hormone agonist. Fertil Steril 1990; 54: 233-7.
12. Tan SL, Kingsland C, Campbell S, Mills C, Bradfield J, Alexander N, Yovich J, Jacobs HS. The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilisation. Fertil Steril 1992; 57: 810-4.
13. Oyesanya OA, Teo SK, Quah E, Abdurazak N, Lee FY, Cheng WC. Pituitary down-regulation prior to in-vitro fertilization and embryo transfer: a comparison between a single dose of Zoladex depot and multiple daily doses of Suprefact. Hum Reprod 1995; 10: 1042-4.
14. Hsieh Y, Tsai H, Chang C, Lo H. Comparison of a single half-dose, long-acting form of gonadotropin-releasing hormone analog (GnRHa) and a short-acting form of GnRH-a for pituitary suppression in a controlled ovarian hyperstimulation program. Fertil Steril 2000; 73: 817-20.
15. El-Nemr A, Bhide M, Khalifa Y, Al-Mizyen E, Gillott C, Lower AM, Al-Shawaf T, Grudzinskas JG. Clinical evaluation of three different gonadotrophin-releasing hormone analogues in an IVF programme: a prospective study. Eur J Obstet Gynecol Reprod Biol 2002; 103: 140-5.
16. Geber S, Sales L, Sampaio MA. Comparison between a single dose of goserelin (Depot) and multiple daily doses of leuprolide acetate for pituitary suppression in IVF treatment: a clinical endocrinological study of the ovarian response. J Assist Reprod Genet 2002; 19: 313-8.
17. Albuquerque LE, Saconato H, Maciel MC, Baracat EC, Freitas V. Depot versus daily administration of GnRH agonist protocols for pituitary desensitization in assisted reproduction cycles: a Cochrane review. Hum Reprod 2003; 18: 2008-17.
18. Cheon KW, Byun HK, Yang KM, Song IO, Choi KH, Yoo KJ. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques. J Reprod Med 2004; 49: 733-8.
19. Wasser SK, Sewall G, Soules MR. Psychosocial stress as a cause of infertility. Fertil Steril 1993; 59: 685-9.
20. Pang SC. A pen injection device for self-administration of recombinant follicle-stimulating hormone for fertility treatments. Expert Rev Med Devices 2005; 2: 27-32.
21. Tapanainen J, Hovatta O, Juntunen K, Martikainen H, Ratsula K, Tulppala M, Tuomivaara L. Subcutaneous goserelin versus intranasal buserelin for pituitary down-regulation in patients undergoing IVF: a randomized comparative study. Hum Reprod 1993; 8: 2052-5.
22. Tsai HD, Chen CM, Lo HY, Chang CC. Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization. Hum Reprod 1995; 10: 2909-12.
23. Dada T, Salha O, Baillie HS, Sharma V. A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme: a prospective randomized study. Hum Reprod 1999; 14: 288-93.
24. Dal Prato L, Borini A, Trevisi MR, Bonu MA, Sereni E, Flamigni C. Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study. Hum Reprod 2001; 16: 1409-14.